Equities

Vaxart Inc

Vaxart Inc

Actions
  • Price (MXN)12.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Jul 16 2024 15:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4096166
Total Receivables, Net3.010.020.07
Total Inventory------
Prepaid expenses2.823.712.61
Other current assets, total------
Total current assets4699169
Property, plant & equipment, net374120
Goodwill, net4.514.514.51
Intangibles, net4.295.0211
Long term investments--016
Note receivable - long term------
Other long term assets0.933.570.89
Total assets92154221
LIABILITIES
Accounts payable1.585.513.87
Accrued expenses7.808.445.34
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.800.100.84
Other current liabilities, total0.543.870.74
Total current liabilities141811
Total long term debt2.625.6211
Total debt6.435.7212
Deferred income tax------
Minority interest------
Other liabilities, total182012
Total liabilities344334
SHAREHOLDERS EQUITY
Common stock0.020.010.01
Additional paid-in capital468438407
Retained earnings (accumulated deficit)(410)(327)(219)
Treasury stock - common(0.37)----
Unrealized gain (loss)------
Other equity, total0.00(0.3)(0.07)
Total equity58111188
Total liabilities & shareholders' equity92154221
Total common shares outstanding153134126
Treasury shares - common primary issue0.5100
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.